Your session is about to expire
← Back to Search
Device
Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus (NPH Trial)
N/A
Waitlist Available
Led By Laura Pare, MD, FRCSC
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 min per clinic visit
Awards & highlights
No Placebo-Only Group
Summary
The research project is designed to determine which combination of tests will enable physicians to predict whether a patient with symptoms of normal pressure hydrocephalus (NPH) will improve with a shunt.
Eligible Conditions
- Normal Pressure Hydrocephalus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ initial and follow-up visits
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial and follow-up visits
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Evans Ratio
Secondary study objectives
Physical Therapy, Occupational Therapy, and Speech Therapy
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Comparison for patients of lumbar drain and shunt surgeryExperimental Treatment2 Interventions
Subjective comparisons made for patients - before and after external lumbar drain, before and after shunt surgery.
Device: Programmable Shunt Insertion (Codman Medtronic)
Behavioral: Assessments in physical therapy, occupational therapy, and speech therapy
Follow-up testing to be administered by trained physician assistant in the outpatient setting on an approximately monthly basis: 10m walk, timed up-and-go, mini-mental status exam, 9-hole grooved pegboard, motor visual perception test (MVPT), modified rankin score (MRS)
Find a Location
Who is running the clinical trial?
University of California, IrvineLead Sponsor
566 Previous Clinical Trials
1,933,024 Total Patients Enrolled
Laura Pare, MD, FRCSCPrincipal InvestigatorUC Irvine